BLOOD CANCER BREAKTHROUGH!
Globe|April 11, 2022
New chemo zaps cancer while leaving healthy cells untouched
BLOOD CANCER BREAKTHROUGH!

REVOLUTIONARY manmade antibodies may help some lymphoma patients substantially cut the risk of a blood cancer relapse while eliminating the need for traditional, damaging chemotherapy, a recent medical trial suggests.

Delivered via an infusion, the medication Polivy — also known as polatuzumab vedotin-piiq uses artificial proteins to carry chemotherapy directly to cancer cells to destroy them while leaving healthy tissue unscathed.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.